PT  - JOURNAL ARTICLE
AU  - Andrés Aranda-Díaz
AU  - Elizabeth Imbert
AU  - Sarah Strieff
AU  - Dave Graham-Squire
AU  - Jennifer L Evans
AU  - Jamie Moore
AU  - Willi McFarland
AU  - Jonathan Fuchs
AU  - Margaret A Handley
AU  - Margot Kushel
TI  - Implementation of Rapid and Frequent SARS-CoV2 Antigen Testing and Response in Congregate Homeless Shelters
AID  - 10.1101/2021.04.20.21255787
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.20.21255787
4099  - http://medrxiv.org/content/early/2021/04/27/2021.04.20.21255787.short
4100  - http://medrxiv.org/content/early/2021/04/27/2021.04.20.21255787.full
AB  - Background People experiencing homelessness who live in congregate shelters are at high risk of SARS-CoV2 transmission and severe COVID-19. Current screening and response protocols using rRT-PCR in homeless shelters are expensive, require specialized staff and have delays in returning results and implementing responses.Methods We piloted a program to offer frequent, rapid antigen-based tests (BinaxNOW) to residents and staff of congregate-living shelters in San Francisco, California, from January 15th to February 19th, 2021. We used the Reach-Effectiveness-Adoption-Implementation-Maintenance (RE-AIM) framework to evaluate the implementation.Reach We offered testing at ten of twelve eligible shelters. Shelter residents and staff had variable participation across shelters; approximately half of eligible individuals tested at least once; few tested consistently during the study.Effectiveness 2.2% of participants tested positive. We identified three outbreaks, but none exceeded 5 cases. All BinaxNOW-positive participants were isolated or left the shelters.Adoption We offered testing to all eligible participants within weeks of the project’s initiation.Implementation Adaptations made to increase reach and improve consistency were promptly implemented.Maintenance San Francisco Department of Public Health expanded and maintained testing with minimal support after the end of the pilot.Conclusion Rapid and frequent antigen testing for SARS-CoV2 in homeless shelters is a viable alternative to rRT-PCR testing that can lead to immediate isolation of infectious individuals. Using the RE-AIM framework, we evaluated and adapted interventions to enable the expansion and maintenance of protocols.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe project received funding from the UCSF Benioff Homelessness and Housing Initiative, Kaiser Community Benefits, and Heluna Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The UCSF Committee on Human Research granted a public health surveillance exemption.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is contained within the manuscript